overview icon Overview

The Value of Increasing Diversity in Clinical Trials


The underrepresentation of diverse populations in clinical trials creates knowledge gaps about the risks and benefits of drugs and devices for the public.

CTTI is addressing the value of including diverse patient populations in clinical trials throughout the development lifecycle of medical products—from early target identification through clinical trial conduct to increase research discoveries is vital. Forthcoming recommendations and resources will help stakeholders adopt new organizational level practices that increase diversity in clinical trials and, thereby, better identify population-level differences in treatment response, safety, and efficacy.

Project Team Members

Role Name Affiliationsort ascending
Team Leader Tesheia Johnson Yale University
Team Member Kelley O'Donoghue University of Rochester
Team Member Natalie Holick University of Kansas Medical Center
Team Member Jerrihlyn McGee University of Kansas Medical Center
Team Leader Bernadete Siddiqi The Michael J Fox Foundation for Parkinson's Research
Team Member Maria Ali The George Institute for Global Health
Team Member Jane Williams Syneos Health
Team Member Glendon Zinser Susan G Komen
Team Member Diana Foster Society for Clinical Research Sites
Team Member Karlin Schroeder Parkinson's Foundation
Team Member Suzanne Maahs Novartis
Team Member Heidi Pereira Novartis
Team Member Christina Brennan Northwell Health
Team Leader Dawn Corbett National Institutes of Health
Team Member Patricia Jones National Institutes of Health
Team Leader Luther Clark Merck & Company, Inc
Team Member Cassandra Beisel Melanoma Research Foundation
Team Member Beverly Lorell King & Spalding LLP
Team Member Cassandra Smith Johnson & Johnson/Janssen
Team Member Kimberly Fisher Janssen
Team Member Jamil Rivers Individual Patient/Caregiver
Team Member Susan Burriss GlaxoSmithKline
Team Member Julia Yegorova Genentech-a member of the Roche Group
Team Member Ruma Bhagat Genentech-a member of the Roche Group
Team Member Kaveeta Vasisht Food and Drug Administration/OC
Team Leader Richardae Araojo Food and Drug Administration/OC
EC Champion Robert Temple Food and Drug Administration/CDER
Team Member Melania Boyce EMD Serono
Team Member Coleman Obasaju Eli Lilly and Company
Team Member Kevin Thomas Duke University
Team Member Jeffrey Sherman Drug Information Association
Team Member Kimberly Carlson Department of Veterans Affairs
Project Manager Sara Calvert Clinical Trials Transformation Initiative
Team Member Jaime Arango CITI Program, a Division of BRANY
Team Member Cecelia Belamonte Amgen Inc
Team Member Arisha Ali Amgen Inc
Team Member Patricia Hurley American Society of Clinical Oncology